Cite Filings / STLN / 0001628280-22-013932

Feed Companies Filings Check

Sign in

8-K

Current Report

Starling Oncology, Inc. Filed 2022-05-12 Acc 0001628280-22-013932

Other events

Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

8-K Current Report , toi-20220512.htm

Around this filing

2022-07-15 8-K Shareholder vote results
2022-05-13 4 10% owner sold 1,600,000 shares at $6.00 ($9,600,000)
2022-05-12 424B3 Prospectus
2022-05-12 8-K Other events
2022-05-12 S-8 Securities Offered to Employees in Benefit Plans
2022-05-11 8-K Results of operations · Regulation FD disclosure
2022-05-11 424B3 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading toi-20220512.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…